Published in Circulation on September 08, 1998
Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol (2007) 1.58
Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther (2010) 1.41
An isolated perfused pig heart model for the development, validation and translation of novel cardiovascular magnetic resonance techniques. J Cardiovasc Magn Reson (2010) 1.14
Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol (2002) 1.06
Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail Rev (2007) 1.02
Ischemic preconditioning attenuates mitochondrial localization of PTEN induced by ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2011) 1.00
Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? Br J Pharmacol (2014) 0.93
Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism. Br J Pharmacol (2000) 0.93
Therapeutic receptor targets of ischemic preconditioning. Cardiovasc Res (2002) 0.89
Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor. J Mol Cell Cardiol (2010) 0.88
Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway. Br J Pharmacol (2005) 0.87
A minimally invasive method for induction of myocardial infarction in an animal model using tungsten spirals. Int J Cardiovasc Imaging (2009) 0.85
Transauricular embolization of the rabbit coronary artery for experimental myocardial infarction: comparison of a minimally invasive closed-chest model with open-chest surgery. J Cardiothorac Surg (2012) 0.80
Organ preconditioning: the past, current status, and related lung studies. J Zhejiang Univ Sci B (2006) 0.80
Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS. Basic Res Cardiol (2011) 0.79
Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs. Br J Pharmacol (2003) 0.78
A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart. Br J Pharmacol (2005) 0.78
[Norepinephrine of the rat myocardium during repeated ischemia]. Ross Fiziol Zh Im I M Sechenova (2007) 0.75
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept. Pharmaceuticals (Basel) (2010) 0.75
Combination of remote ischemic perconditioning and remote ischemic postconditioning fails to increase protection against myocardial ischemia/reperfusion injury, compared with either alone. Mol Med Rep (2015) 0.75
Extracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning. PLoS One (2015) 0.75
Determinants of delayed preconditioning against myocardial stunning in chronically-instrumented pigs. J Cardiovasc Transl Res (2009) 0.75
The impact of a single episode of remote ischemic preconditioning on myocardial injury after elective percutaneous coronary intervention. Postepy Kardiol Interwencyjnej (2017) 0.75
Bradykinin and angiotensin-converting enzyme inhibition in cardioprotection. Exp Clin Cardiol (2004) 0.75
Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention. Curr Cardiol Rev (2008) 0.75
Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res (2000) 3.19
MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology (2000) 2.77
Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation (1999) 2.20
Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation. Acta Anaesthesiol Scand (2014) 2.02
Family participation during resuscitation: an option. Ann Emerg Med (1987) 1.87
Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res (2000) 1.71
Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol (1998) 1.69
Low-frequency spectral power of heart rate variability is not a specific marker of cardiac sympathetic modulation. Anesthesiology (1995) 1.65
Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation. Circ Res (1992) 1.54
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand (2011) 1.53
Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol (2001) 1.49
Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy. Heart (2007) 1.45
Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res (2001) 1.43
Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation (1993) 1.41
Positron emission tomography analysis of [1-(11)C] acetate kinetics in short-term hibernating myocardium. Circulation (1998) 1.40
Transcutaneous pCO2-monitoring for the evaluation of the anaerobic threshold. Comparison to lactate and ventilatory thresholds. Int J Sports Med (1993) 1.38
Unique cardioprotective action of the new calcium antagonist mibefradil. Circulation (1999) 1.38
Signal transduction of ischemic preconditioning. Cardiovasc Res (2001) 1.38
[The pathophysiology of myocardial circulation. I. Adaptation to myocardial ischemia (the "hibernating" myocardium)]. Dtsch Med Wochenschr (1994) 1.37
Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation (1991) 1.16
G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res (1999) 1.15
Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation (1999) 1.14
Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J Mol Cell Cardiol (2004) 1.13
Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol (1994) 1.12
Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol (2000) 1.10
Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol (2000) 1.10
Coronary microembolization. J Am Coll Cardiol (2000) 1.07
Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res (1987) 1.04
Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Circulation (1987) 1.03
Ischaemic preconditioning: present position and future directions. Cardiovasc Res (1998) 1.02
The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog. Circ Res (1983) 1.00
The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. J Cardiovasc Pharmacol (1992) 1.00
Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol (1990) 1.00
Intraischemic preconditioning. Increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia without intermittent reperfusion. Circ Res (1995) 1.00
Improved assessment of coronary stenosis severity using the relative flow velocity reserve. Circulation (1998) 1.00
Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation (2001) 0.99
Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am J Physiol (1999) 0.99
Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.99
Myocardial lactate release during ischemia in swine. Relation to regional blood flow. Circulation (1990) 0.98
Trifluorothymidine versus adenine arabinoside in the treatment of herpes simplex keratitis. Br J Ophthalmol (1980) 0.97
Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am J Cardiol (1999) 0.97
Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? Circulation (2001) 0.96
Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch (1995) 0.95
Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol (2000) 0.95
Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Circulation (1994) 0.95
The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg (2012) 0.95
eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol (2001) 0.94
Impact of alpha-adrenergic coronary vasoconstriction on the transmural myocardial blood flow distribution during humoral and neuronal adrenergic activation. Circ Res (1993) 0.94
Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? Br J Pharmacol (2014) 0.93
Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism. Br J Pharmacol (2000) 0.93
Connexin 43 signalling and cardioprotection. Heart (2005) 0.93
Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circulation (1987) 0.93
No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. J Mol Cell Cardiol (2000) 0.91
The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits. Br J Pharmacol (2010) 0.90
Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol (1984) 0.90
Left ventricular asynchrony: an indicator of regional myocardial dysfunction. Am Heart J (1990) 0.89
Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion. J Mol Cell Cardiol (2000) 0.89
Consequences of regional inotropic stimulation of ischemic myocardium on regional myocardial blood flow and function in anesthetized swine. Circ Res (1989) 0.88
No effect of coronary perfusion on regional myocardial function within the autoregulatory range in pigs. Evidence against the Gregg phenomenon. Circulation (1991) 0.87
Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol (1998) 0.87
Ischemic myocardial dysfunction assessed by temporal Fourier transform of regional myocardial wall thickening. Am Heart J (1987) 0.87
Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res (1988) 0.86
Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses. J Cardiovasc Pharmacol (1984) 0.86
Acetylcholine induces constriction of epicardial coronary arteries in anesthetized dogs after removal of endothelium. Arzneimittelforschung (1985) 0.86
Static filling pressure in patients during induced ventricular fibrillation. Am J Physiol Heart Circ Physiol (2003) 0.86
Genetic interactions in the β-adrenoceptor/G-protein signal transduction pathway and survival after coronary artery bypass grafting: a pilot study. Br J Anaesth (2011) 0.86
Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation (1996) 0.86
Post-ejection wall thickening as a marker of successful short term hibernation. Cardiovasc Res (1993) 0.86
Inorganic phosphate content and free energy change of ATP hydrolysis in regional short-term hibernating myocardium. Cardiovasc Res (1998) 0.86
Regional myocardial blood flow, function and metabolism using phosphorus-31 nuclear magnetic resonance spectroscopy during ischemia and reperfusion in dogs. J Am Coll Cardiol (1987) 0.85
Relation of olfactory event-related potentials to changes in stimulus concentration. Electroencephalogr Clin Neurophysiol (1998) 0.85
Vesicular transfer of membrane components to bovine epididymal spermatozoa. Cell Tissue Res (2013) 0.85
Heart rate variability and circulating catecholamine concentrations during steady state exercise in healthy volunteers. Br Heart J (1993) 0.85
X-ray densitometry for the measurement of regional myocardial perfusion. Basic Res Cardiol (2000) 0.85
Clonidine prevents the sympathetic initiation and aggravation of poststenotic myocardial ischemia. J Cardiovasc Pharmacol (1986) 0.84
Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs. Am J Physiol Heart Circ Physiol (2001) 0.84
AT1 receptor blockade in experimental myocardial ischemia/reperfusion. Basic Res Cardiol (1998) 0.84
Minimal protection of the liver by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol (2001) 0.84
Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitors. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.84
Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. J Cardiovasc Pharmacol (1995) 0.84
Regional short-term myocardial hibernation in swine does not involve endogenous adenosine or KATP channels. Am J Physiol (1995) 0.84
No involvement of nitric oxide in the limitation of beta-adrenergic inotropic responsiveness during ischemia. Am J Physiol Heart Circ Physiol (2001) 0.84
Are microbubbles free flowing tracers through the Myocardium? Comparison of indicator-dilution curves obtained from dye dilution and echo contrast using harmonic power Doppler imaging. Echocardiography (2000) 0.84
Genetic determinants of coronary vasomotor tone in humans. Am J Physiol Heart Circ Physiol (2001) 0.83
AT1 receptor blockade in experimental myocardial ischemia/reperfusion. J Am Soc Nephrol (1999) 0.83
Accurate T2 NMR images. Med Phys (1984) 0.83
Favorable remodeling enhances recovery of regional myocardial function in the weeks after infarction in ischemically preconditioned hearts. Circulation (2000) 0.82
Characteristics of regional myocardial stunning after exercise in dogs with chronic coronary stenosis. Am J Physiol (1989) 0.82
Predictors of success in radiofrequency catheter ablation of atrial flutter. J Interv Card Electrophysiol (2000) 0.82
Effects of left circumflex Ameroid constrictor placement on adrenergic innervation of myocardium. Am J Physiol (1987) 0.82